Open Access. Powered by Scholars. Published by Universities.®

Social and Behavioral Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Life Sciences

None

Xu-Feng Huang

Selected Works

Alters

Publication Year

Articles 1 - 4 of 4

Full-Text Articles in Social and Behavioral Sciences

Developmental Vitamin D Deficiency Alters Mk-801-Induced Behaviours In Adult Offspring, James Kesby, Jonathan O'Loan, Suzanne Alexander, Chao Deng, Xu-Feng Huang, John Mcgrath, Darryl Eyles, Thomas Burne Feb 2013

Developmental Vitamin D Deficiency Alters Mk-801-Induced Behaviours In Adult Offspring, James Kesby, Jonathan O'Loan, Suzanne Alexander, Chao Deng, Xu-Feng Huang, John Mcgrath, Darryl Eyles, Thomas Burne

Xu-Feng Huang

Rationale Developmental vitamin D (DVD) deficiency is a candidate risk factor for developing schizophrenia in humans. In rodents DVD deficiency induces subtle changes in the way the brain develops. This early developmental insult leads to select behavioural changes in the adult, such as an enhanced response to amphetamine-induced locomotion in female DVD-deficient rats but not in male DVDdeficient rats and an enhanced locomotor response to the Nmethyl- D-aspartate (NMDA) receptor antagonist, MK-801, in male DVD-deficient rats. However, the response to MK- 801-induced locomotion in female DVD-deficient rats is unknown. Therefore, the aim of the current study was to further examine …


Perinatal Administration Of Pcp Alters Adult Behaviour In Female Sprague-Dawley Rats, Teresa Du Bois, Xu-Feng Huang, Chao Deng Sep 2012

Perinatal Administration Of Pcp Alters Adult Behaviour In Female Sprague-Dawley Rats, Teresa Du Bois, Xu-Feng Huang, Chao Deng

Xu-Feng Huang

Perinatal phencyclidine (PCP) treatment leads to neuronal damage and causes long-term behavioural alterations in rodents. This study examined the effects of perinatal PCP treatment on behaviour of adult rats in holeboard, elevated plus maze, social interaction and forced swim tests. PCP-treated rats displayed hyperactivity in the holeboard and forced swim tests. These persistent behavioural changes are relevant to the study of psychiatric disorders such as schizophrenia.


Perinatal Phencyclidine Treatment Alters Neuregulin 1/Erbb4 Expression And Activation In Later Life, Teresa Du Bois, Kelly Newell, Xu-Feng Huang Sep 2012

Perinatal Phencyclidine Treatment Alters Neuregulin 1/Erbb4 Expression And Activation In Later Life, Teresa Du Bois, Kelly Newell, Xu-Feng Huang

Xu-Feng Huang

Schizophrenia is a complex and devastating mental disorder of unknown etiology. Hypofunction of N-methyl-d-aspartate (NMDA) receptors are implicated in the disorder, since phencyclidine (PCP) and other NMDA receptor antagonists mimic schizophrenia-like symptoms in humans and animals so well. Moreover, genetic linkage and post mortem studies strongly suggest a role for altered neuregulin 1 (Nrg1)/erbB4 signaling in schizophrenia pathology. This study investigated the relationship between the NMDA receptor and Nrg1 signaling pathways using the perinatal PCP animal model. Rats (n = 5/group) were treated with PCP (10 mg/kg) or saline on postnatal days (PN) 7, 9 and 11 and were sacrificed …


Perinatal Pcp Treatment Alters The Developmental Expression Of Prefrontal And Hippocampal Muscarinic Receptors, Kelly Newell, Xu-Feng Huang, Chao Deng, Teresa Du Bois, Mei Han Sep 2012

Perinatal Pcp Treatment Alters The Developmental Expression Of Prefrontal And Hippocampal Muscarinic Receptors, Kelly Newell, Xu-Feng Huang, Chao Deng, Teresa Du Bois, Mei Han

Xu-Feng Huang

Perinatal phencyclidine (PCP) treatment has been used to model brain pathological processes that may be present in schizophrenia such as increased apoptosis during early brain development, and long-term alterations in expression of parvalbumin-containing interneurons and glutamatergic N-methyl-d-aspartate (NMDA) receptors. We report that this treatment also affects receptor expression of another excitatory neurotransmitter receptor, the muscarinic receptor. Female rat pups received injections of the NMDA receptor antagonist PCP (10 mg/kg, s.c.) or saline on postnatal days (PN)7, 9 and 11. [3H]Pirenzepine binding to M1/4 receptors was examined at four time-points (PN12, 18, 32 and 96) following treatment cessation. Significant effects of …